Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 1
1953 2
1954 2
1955 2
1956 2
1957 2
1958 2
1960 3
1961 4
1962 4
1963 2
1964 2
1965 3
1966 2
1967 2
1968 4
1969 1
1970 2
1971 4
1972 2
1973 1
1974 2
1975 2
1976 1
1978 4
1979 1
1982 2
1983 1
1984 1
1985 2
1987 6
1988 3
1989 5
1990 1
1991 2
1992 1
1993 6
1994 1
1995 2
1996 1
1997 1
1998 3
1999 3
2000 3
2001 3
2002 2
2003 5
2004 13
2005 11
2006 12
2007 7
2008 9
2009 7
2010 11
2011 10
2012 13
2013 13
2014 7
2015 6
2016 12
2017 10
2018 9
2019 10
2020 12
2021 11
2022 15
2023 18
2024 17

Text availability

Article attribute

Article type

Publication date

Search Results

318 results

Results by year

Filters applied: . Clear all
Page 1
Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology.
Thompson JA, Schneider BJ, Brahmer J, Achufusi A, Armand P, Berkenstock MK, Bhatia S, Budde LE, Chokshi S, Davies M, Elshoury A, Gesthalter Y, Hegde A, Jain M, Kaffenberger BH, Lechner MG, Li T, Marr A, McGettigan S, McPherson J, Medina T, Mohindra NA, Olszanski AJ, Oluwole O, Patel SP, Patil P, Reddy S, Ryder M, Santomasso B, Shofer S, Sosman JA, Wang Y, Zaha VG, Lyons M, Dwyer M, Hang L. Thompson JA, et al. Among authors: marr a. J Natl Compr Canc Netw. 2022 Apr;20(4):387-405. doi: 10.6004/jnccn.2022.0020. J Natl Compr Canc Netw. 2022. PMID: 35390769 Review.
Perioperative Fluid Management in Surgical Patients: A Review.
Cao A, Bellfi LT, Schoen J, Greiffenstein P, Marr AB, Stuke L, Hunt JP, Pino R, Smith A. Cao A, et al. Among authors: marr ab. Am Surg. 2023 Jun;89(6):2677-2684. doi: 10.1177/00031348221121565. Epub 2022 Aug 17. Am Surg. 2023. PMID: 35977846 Review.
A community approach to the cancer-variant-interpretation bottleneck.
Krysiak K, Danos AM, Kiwala S, McMichael JF, Coffman AC, Barnell EK, Sheta L, Saliba J, Grisdale CJ, Kujan L, Pema S, Lever J, Spies NC, Chiorean A, Rieke DT, Clark KA, Jani P, Takahashi H, Horak P, Ritter DI, Zhou X, Ainscough BJ, Delong S, Lamping M, Marr AR, Li BV, Lin WH, Terraf P, Salama Y, Campbell KM, Farncombe KM, Ji J, Zhao X, Xu X, Kanagal-Shamanna R, Cotto KC, Skidmore ZL, Walker JR, Zhang J, Milosavljevic A, Patel RY, Giles RH, Kim RH, Schriml LM, Mardis ER, Jones SJM, Raca G, Rao S, Madhavan S, Wagner AH, Griffith OL, Griffith M. Krysiak K, et al. Among authors: marr ar. Nat Cancer. 2022 May;3(5):522-525. doi: 10.1038/s43018-022-00379-w. Nat Cancer. 2022. PMID: 35624339 Free PMC article.
Predictors of Inappropriate Helicopter Transport.
Brown C, Irfan W, Schoen JE, Marr AB, Stuke LE, Cavalea AC, Mosier WW, Rogers CL, Greiffenstein PP, Moore MM, Hunt JP. Brown C, et al. Among authors: marr ab. Am Surg. 2021 Feb;87(2):248-252. doi: 10.1177/0003134820951423. Epub 2020 Sep 15. Am Surg. 2021. PMID: 32927969
Traumatic Breast Injuries in High-Risk Communities.
Vazquez Perez A, Deville P, Hargis M, Hunt JP, Marr AB, Stuke LE, Schoen JE, Greiffenstein PP, Smith AA. Vazquez Perez A, et al. Among authors: marr ab. Am Surg. 2023 Dec;89(12):6351-6352. doi: 10.1177/00031348231174020. Epub 2023 May 11. Am Surg. 2023. PMID: 37166837 No abstract available.
Pembrolizumab in Patients With Tumors With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry Study.
Duvivier HL, Rothe M, Mangat PK, Garrett-Mayer E, Ahn ER, Al Baghdadi T, Alva AS, Dublis SA, Cannon TL, Calfa CJ, Li R, Behl D, Chiu VK, Gold PJ, Marr AS, Mileham KF, Powell SF, Rodon J, Thota R, Grantham GN, Gregory A, Hinshaw DC, Halabi S, Schilsky RL. Duvivier HL, et al. Among authors: marr as. J Clin Oncol. 2023 Nov 20;41(33):5140-5150. doi: 10.1200/JCO.23.00702. Epub 2023 Aug 10. J Clin Oncol. 2023. PMID: 37561967
The REACT study: design of a randomized phase 3 trial to assess the efficacy and safety of clazosentan for preventing deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
Bruder N, Higashida R, Santin-Janin H, Dubois C, Aldrich EF, Marr A, Roux S, Mayer SA. Bruder N, et al. Among authors: marr a. BMC Neurol. 2022 Dec 20;22(1):492. doi: 10.1186/s12883-022-03002-8. BMC Neurol. 2022. PMID: 36539711 Free PMC article. Clinical Trial.
Growth rate of Escherichia coli.
Marr AG. Marr AG. Microbiol Rev. 1991 Jun;55(2):316-33. doi: 10.1128/mr.55.2.316-333.1991. Microbiol Rev. 1991. PMID: 1886524 Free PMC article. Review.
Improving Conversations about Parkinson's Dementia.
Dobreva I, Thomas J, Marr A, O'Connell R, Roche M, Hannaway N, Dore C, Rose S, Liu K, Bhome R, Baldwin-Jones S, Roberts J, Archibald N, Alston D, Amar K, Edwards E, Foley JA, Haunton VJ, Henderson EJ, Jha A, Lindop F, Magee C, Massey L, Ruiz-Mendoza E, Mohamed B, Patterson K, Ramaswamy B, Schrag A, Silverdale M, Suárez-González A, Subramanian I, Foltynie T, Williams-Gray CH, Yarnall AJ, Carroll C, Bale C, Hugill C, Weil RS. Dobreva I, et al. Among authors: marr a. Mov Disord Clin Pract. 2024 Jul;11(7):814-824. doi: 10.1002/mdc3.14054. Epub 2024 May 2. Mov Disord Clin Pract. 2024. PMID: 38696333 Free PMC article.
318 results